share_log
Breakings ·  Sep 20 06:18

Zhaoke Ophthalmology, a Hong Kong Stock Exchange announcement, announced that Beimei Prostaglandin Eye Drops (Jingbeiqing) has been approved for marketing by the National Medical Products Administration (NMPA).

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment